Description
CHEMISTRY-IMMUNO COST PER REPORTABLE RESULTS
First action · last action
2012-10-11 · 2012-10-11
Transactions
1
First transaction's obligation
$704,595
Base + all options value (sum of deltas)
$704,595
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA256BP0103
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-10-11+$704,595= $704,595
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-10-11 | +$704,595 | $704,595 | CHEMISTRY-IMMUNO COST PER REPORTABLE RESULTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PU6HHX2R11C7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0869 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $111,853 | FY2026 |
| 36C25726N0476 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,450,556 | FY2026 |
| 36C25926N0424 | NETWORK CONTRACT OFFICE 19 (36C259) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $2,989,154 | FY2026 |
| 36C25726N0456 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $365,580 | FY2026 |
| 36C24426N0923 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $84,816 | FY2026 |
| 36C24426N0922 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $46,600 | FY2026 |
Other recipients under 6550 from 635-OKLAHOMA CITY (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25614F3714 | CEPHEID | 635-OKLAHOMA CITY | $100,687 | FY2014 |
| VA25613J0095 | ABBOTT RAPID DX NORTH AMERICA LLC | 635-OKLAHOMA CITY | $107,250 | FY2013 |
| VA25612F2060 | ROCHE DIAGNOSTICS CORPORATION | 635-OKLAHOMA CITY | $40,592 | FY2012 |
| VA25612F1714 | ABBOTT RAPID DX NORTH AMERICA LLC | 635-OKLAHOMA CITY | $22,000 | FY2012 |
| VA25612F1684 | ROCHE DIAGNOSTICS CORPORATION | 635-OKLAHOMA CITY | $8,424 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25613J0089_3600_VA256BP0103_3600 · retrieved 2026-09-27.